Nuvectis Pharma, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Nuvectis Pharma, Inc. (NVCT) is 341.45M

According to Nuvectis Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 341.45M. This represents a change of 161.12% compared to the average of 130.76M of the last 4 quarters.

Nuvectis Pharma, Inc. (NVCT) Historical Enterprise Value (quarterly & annually)

How has NVCT Enterprise Value performed in the past?

The mean historical Enterprise Value of Nuvectis Pharma, Inc. over the last ten years is 78.26M. The current 341.45M Enterprise Value has changed 43.53% with respect to the historical average. Over the past ten years (40 quarters), NVCT's Enterprise Value was at its highest in in the June 2023 quarter at 217.79M. The Enterprise Value was at its lowest in in the June 2021 quarter at 34.12M.

Nuvectis Pharma, Inc. (NVCT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nuvectis Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nuvectis Pharma, Inc. (NVCT) Average Enterprise Value

How has NVCT Enterprise Value performed in the past?

The current Enterprise Value of Nuvectis Pharma, Inc. (NVCT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nuvectis Pharma, Inc. (NVCT) Enterprise Value vs. Peers

How is NVCT’s Enterprise Value compared to its peers?

Nuvectis Pharma, Inc.’s Enterprise Value is greater than Innate Pharma S.A. (145.48M), greater than Compugen Ltd. (180.55M), greater than Milestone Pharmaceuticals Inc. (177.67M), greater than Tonix Pharmaceuticals Holding Corp. (7.27M), greater than Cybin Inc. (-84061835.96), greater than Rani Therapeutics Holdings, Inc. (45.40M), greater than Cardiff Oncology, Inc. (74.83M), less than Armata Pharmaceuticals, Inc. (628.83M), greater than Molecular Partners AG (40.49M), greater than Cassava Sciences, Inc. (-27637367.00),

Build a custom stock screener for Nuvectis Pharma, Inc. (NVCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuvectis Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nuvectis Pharma, Inc. (NVCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nuvectis Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.